Recent studies also showed that ANXA2 knockdown inhibits proliferation and invasion of canine GBM cell lines35, human glioma U251, U8736 and U118 cells37, primary patient-derived glioma cells33, 35 and GBM stem-like cells33, 35. This evidence concerns the gene ANXA2 and central nervous system cancer.